Multiple Myeloma
Multiple myeloma Definition Multiple myeloma is a cancer in which antibody-producing plasma cells grow in an uncontrolled and invasive (malignant) manner. Description Multiple myeloma, also known as plasma cell myeloma, is the second-most common cancer of the blood. It is the most common type of
The role of high-dose chemotherapy supported by hematopoietic stem cell transplantation in patients with multiple myeloma: implications for nursing.
Multiple myeloma (MM), a neoplastic proliferation of plasma cells originating from the B-cell line, is associated with deleterious complications and poor outcomes. The failure of conventional combination chemotherapies to improve the overall survival of patients with MM has led to the use of
Multiple myeloma
INTRODUCTION Multiple myeloma is a cancer caused by malignant plasma cells. This disease is a hematologic cancer that affects many people. There are a number of risks that are associated with multiple myeloma, although nothing strictly predisposes the disease. The number of multiple myeloma cases
Multiple myeloma.
Objectives: After completing this article, readers should be able to: * Recognize the signs and symptoms of multiple myeloma. * Discuss the process used to confirm a multiple myeloma diagnosis. * Identify imaging modalities used to diagnose the disease. * Describe the appearance of multiple myeloma
Primer on medical genomics part IX: Scientific and clinical applications of DNA microarrays-multiple myeloma as a disease model
Multiple myeloma (MM) is a poorly understood and uniformly fatal malignancy of antibody-secreting plasma cells. Although several key molecular events in disease initiation or progression have been confirmed (eg, 14q32 translocations) or implicated (eg, chromosome 13 deletion), a unifying mechanism
Nonsecretory multiple myeloma.
ABSTRACT: Nonsecretory multiple myeloma (NSMM) is a rare variant of the classic form of multiple myeloma (MM) and accounts for 1% to 5% of all cases of MM. The clinical presentation and radiographic findings of NSMM and MM are the same. The diagnosis of MM requires the detection of a monoclonal
Multiple myeloma in a patient with hoarseness, dysphagia, aspiration, and cervical lymphadenopathy.
Abstract Multiple myeloma, which primarily affects the elderly, is rare in the head and neck. We report the case of a 71-year-old man who came to us with hoarseness, dysphagia, intermittent aspiration, and cervical lymphadenopathy. Our work-up included laboratory tests, radiographic examinations,
Physical Therapy Management of Patients with Multiple Myeloma: Musculoskeletal Considerations
ABSTRACT Multiple myeloma is a cancer of the plasma cells which significantly impacts the musculoskeletal system. Physical therapists may play an important role in various stages of the progression of this disease. The purpose of this article is to describe the role of the physical therapist along
The Multiple Myeloma Research Foundation Announces 2002 Research Award Recipients; $1.6 million awarded to accelerate cutting-edge multiple myeloma research.
NEW CANAAN, Conn. - The Multiple Myeloma Research Foundation (MMRF), the world's largest private funder of myeloma-specific research, today announced the awarding of 20 research grants worth nearly $1.6 million through its Research Awards program. The grant programs that were funded include the
Thalidomide Therapy and Deep Venous Thrombosis in Multiple Myeloma
The treatment of multiple myeloma (MM) has undergone radical changes in recent years with the arrival of active agents such as thalidomide and bortezomib.1-4 Thalidomide, once discarded because of its teratogenicity, is now widely used alone or in combination with other active drugs to treat
